News from other sources ...

Information technology

The Trump administration's call on Thursday to slash almost 20 percent of the National Institutes of Health's budget led scientists to warn that such cuts would sap biomedical research in the U.S. But it also left many of them with more personal feelings: Anxiety. Fear. Sadness.

Common blood tests can help predict chronic disease risk | NPR

A score based on common blood tests may someday help people gauge their risk of developing a chronic disease like diabetes or dementia within the next three years.

Medical devices and equipment

Alivecor announced $30 million in Series D funding on Thursday from Mayo Clinic and Omron Healthcare. It had previously received $13.5 million in venture funding from investors including Kholsa Ventures and Qualcomm.

Pharmaceuticals

The first rigorous test of an expensive new drug that radically lowers cholesterol levels found that it significantly reduced the chance that a high-risk patient would have a heart attack or stroke. These were men and women who had exhausted all other options.

Medtronic heart valve replacement succeeds in intermediate-risk patients: study | Reuters

Medtronic's non-invasive transcatheter aortic valve replacement (TAVR) system proved as safe as traditional surgery in intermediate-risk patients in a two-year study presented on Friday, paving the way for its use in a wider patient population.

Physicians

This Friday is Match Day, an annual rite of passage for seniors in medical school, when they find out at noon if they've "matched" with a residency in the specialty and location of their choice. But many of those being matched will be happy to go pretty much anywhere. They are international medical graduates — either U.S citizens who've attended school out of the country (think the Caribbean or Mexico) or doctors who are citizens of other countries and want to train here.